As the first part of a wider inquiry into the impact of drugs policy on public health, the Committee sought evidence on the usage of medicinal cannabis products. The Committee invited written submissions answering the following:
- What does the current evidence base tell us about the efficacy of medicinal cannabis?
- What plans are there for research into the medicinal use of cannabis, and what challenges are faced by that research?
- How suitable are the current procedures for enabling the use of medicinal cannabis in appropriate cases?
- Do practitioners have the knowledge and products available to them to confidently prescribe medicinal cannabis?
- Is the current guidance around prescribing CDMPs fit for purpose?
- What can we learn from the legalisation of medicinal cannabis and its practical implementation in other countries?
- Have recent changes in the scheduling and availability of CDMP, and media attention around this, affected public opinion and behaviours in the UK?